Digital Histopathology Deployment in GSK Non-Clinical Histology Facility
Currently, the Pathology community examines relatively small numbers of digital images of H&E stained histological sections for internal consultation and peer review harmonization.
The Non-Clinical Histology team at GSK focused on a new digital histopathology imaging workflow that will define the standards for histopathology in drug discovery/development for the wider GSK scientific community and expectations for external collaborators. By consolidating metadata standards, governance and data entry systems, the digital histopathology imaging workflow will enable increased application of quantitative image analytic approaches like artificial intelligence to clinical and nonclinical biomarker assays.
For Research Use Only. Not for use in diagnostic procedures.
Related Content
Leica Biosystems content is subject to the Leica Biosystems website terms of use, available at: Legal Notice. The content, including webinars, training presentations and related materials is intended to provide general information regarding particular subjects of interest to health care professionals and is not intended to be, and should not be construed as, medical, regulatory or legal advice. The views and opinions expressed in any third-party content reflect the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents. Any links contained in the content which provides access to third party resources or content is provided for convenience only.
For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted.
Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.